S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis by Lisa Reinhard (188324)

“…In PSC patients, the biliary S100A9 expression was elevated 95-fold (p<0.005), serum protein expression was decreased, and pancreatic enzyme expression was unchanged compared to controls. …”

Apoptosis induction, caspase-8 cleavage, and the decrease in c-FLIP levels due to DX1 treatment in NB4, HP100-1 and K562 cells. by Zhiying Yu (356965)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Composition of posts in a hypothetical online conversation among 100 responders who are representative of our sample. by Christopher L. Quarles (12501186)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)

Forest plot of subgroup analysis for postoperative decrease in serum albumin (ΔAlb) in the validation cohort (VC). by Fumihiko Kinoshita (6655172)

Forest plot of subgroup analysis for postoperative decrease in serum albumin (ΔAlb) in the training cohort (TC). by Fumihiko Kinoshita (6655172)

Inverse Relationship between IGF-1 induced Cyr61 upregulation and decreased E-cadherin and FOXO1 expression is confirmed in two cell lines. by Suren Sarkissyan (388555)

LY294002 decreases flagellin-induced Akt/mTOR activation but does not affect p44/42 MAPK (Erk1/2) activation. by Wenlei Bao (735037)

CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

“…Scale bars = 100 μm. (C) Representative flow cytometry profiles showing the decreased percentages of Flk1+ cells in P19 cells treated with 0.32 μM CsA during EB formation for 48 and 96 h, respectively. …”

GluN2A(D731N) decreases current amplitudes and shortens synaptic-like response time course. by Kai Gao (120150)

Supplementary Material for: Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa by Batycka-Baran A. (9650738)

“…The serum concentration of S100A7 in individuals with HS was decreased as compared to healthy controls and patients with psoriasis. …”

Characteristics of participants and prevalence of workplace violence and types per 100 Healthcare workers. by Javier A. Flores-Cohaila (16933983)

Residual sensitivity after decomposition of the triple sensitivities into NN-terms (Eq. (17)). by Hans Binder (128524)

Genes whose expression was decreased in RASMC subjected to Na⁺,K⁺-ATPase inhibition. by Svetlana V. Koltsova (321381)

“…Given <i>in italics</i> are genes whose differential expression was detected in ischemic tissue by whole genome microarray-based analysis <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Mazzatti1" target="_blank">[12]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Leonard1" target="_blank">[18]</a>. …”

Sodium levels (mg/100 g) in matched restaurant menu items in 2016 and 2020 by UK NSRI food categories with ≥ 10 items. by Caroline G. Middleton (22041479)

SP-D treatment results in a decrease in infectivity. by Kelly A. Soltysiak (795758)

Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma by Jie Chen (5892)

“…We found two N-glycan structures (NG1A2F, Peak3; NA2FB, Peak7) showed the optimum diagnostic efficacy with area under the ROC curve (AUC) 0.939 and 0.940 between LCMM and healthy control. …”

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)